GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mabpharm Ltd (HKSE:02181) » Definitions » Pre-Tax Income

Mabpharm (HKSE:02181) Pre-Tax Income : HK$-228.99 Mil (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Mabpharm Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Mabpharm's pretax income for the six months ended in Dec. 2023 was HK$-119.61 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-228.99 Mil. Mabpharm's pretax margin was -253.49%.

During the past 7 years, Mabpharm's highest Pretax Margin was -240.19%. The lowest was -377.02%. And the median was -352.00%.


Mabpharm Pre-Tax Income Historical Data

The historical data trend for Mabpharm's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mabpharm Pre-Tax Income Chart

Mabpharm Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial -225.36 -218.87 -357.23 -235.43 -228.99

Mabpharm Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -179.49 -136.92 -104.98 -109.38 -119.61

Competitive Comparison of Mabpharm's Pre-Tax Income

For the Biotechnology subindustry, Mabpharm's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mabpharm's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mabpharm's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Mabpharm's Pre-Tax Income falls into.



Mabpharm Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Mabpharm's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-216.88+0+-10.476+0.165+-1.798
=-228.99

Mabpharm's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-115.948+0+-5.556+0.143+1.749
=-119.61

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-228.99 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mabpharm  (HKSE:02181) Pre-Tax Income Explanation

Mabpharm's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-119.612/47.187
=-253.49%

During the past 7 years, Mabpharm's highest Pretax Margin was -240.19%. The lowest was -377.02%. And the median was -352.00%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mabpharm Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Mabpharm's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Mabpharm (HKSE:02181) Business Description

Traded in Other Exchanges
N/A
Address
Lujia Road East, Koutai Road West, Block G79, China Medical City, Taizhou, CHN, 225300
Mabpharm Ltd is a biopharmaceutical company. The company is engaged in the research, development, and production of new drugs and biosimilars for cancers and autoimmune diseases. Its core products include CMAB008 (infliximab), CMAB007 (omalizumab), and CMAB009 (cetuximab).
Executives
Guo Jianjun 2307 Founder of a discretionary trust who can infl
Asia Mabtech Limited
Asia Pacific Immunotech Venture Limited
Guo Family (ptc) Limited
Fortune-healthy Investment Limited
Link Best Capital Limited
Cdh Fund V, L.p.
Cdh Mabtech Limited
Cdh V Holdings Company Limited
China Diamond Holdings Company Limited
China Diamond Holdings V Limited

Mabpharm (HKSE:02181) Headlines

No Headlines